ArticleObesity surgery2026
The Association between Anxiety and/or Depression Symptoms with Gastrointestinal Complaints Five Years after Metabolic and Bariatric Surgery - a Cross-sectional Study.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionGastrointestinal (GI) symptoms are common following metabolic and bariatric surgery (MBS) and can significantly impair quality of life. Previous research indicates that anxiety and depressive symptoms could be associated with GI complaints. This study aims to investigate the association between anxiety and/or depressive symptoms and GI complaints five years after MBS.
methodsIn this cross-sectional study 220 participants who underwent MBS were included. Self-reported anxiety and/or depressive symptoms were measured with the Hospital Anxiety and Depression Scale and GI complaints with the Gastrointestinal Symptom Rating Scale. Differences in GI complaint scores between participants with no, mild or severe anxiety and/or depression symptoms were assessed using Kruskal-Wallis and post-hoc tests. Furthermore, the association between anxiety and/or depressive symptom categories and moderately-severe to severe GI complaints (any GRSR item score ≥ 5 out of 7) was assessed by modified Cox regression.
resultsParticipants were on average 50 ± 11 years of age five years post-MBS, mostly female (81%) and predominantly underwent RYGB (87%). 28% reported anxiety and/or depressive symptoms, of which 15% mild and 13% severe. 42% of participants reported moderately-severe to severe GI complaints, of which 20% was severe. Participants with severe anxiety and/or depressive symptoms had significantly higher total and domain GI complaint scores (abdominal pain, reflux syndrome, constipation syndrome) than participants without these symptoms (p<.001). Similar trends were found in participants with mild anxiety and/or depressive symptoms (total p<.001, reflux syndrome p=.048, constipation syndrome p=.005), the association with abdominal pain was on the borderline of significance (p=.05). Participants with mild or severe anxiety and/or depressive symptoms respectively had a 1.75 (95%CI 0.98-3.11; not statistically significant) and 2.55 (95%CI 1.45-4.47) times higher risk (BMI and sleep adjusted prevalence ratio's) of experiencing moderately-severe to severe GI complaints compared to those without.
conclusionParticipants 5-years post-MBS with mild to severe self-reported anxiety and/or depressive symptoms are at a higher risk of reporting more severe GI complaints. These findings underscore the need to assess and refer anxiety and/or depressive symptoms when counselling patients after MBS with GI complaints.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.